The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV

INTRODUCTION: Most clinical trials for new antiretroviral (ARV) agents are conducted among narrowly defined adult populations. Only after safety and efficacy have been clearly demonstrated among adults living with HIV are trials including adolescents, children and infants conducted. This approach co...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojo, Pablo, Carpenter, Deborah, Venter, François, Turkova, Anna, Penazzato, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459170/
https://www.ncbi.nlm.nih.gov/pubmed/32869500
http://dx.doi.org/10.1002/jia2.25576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459170/
https://www.ncbi.nlm.nih.gov/pubmed/32869500
http://dx.doi.org/10.1002/jia2.25576

Ejemplares similares